← back to search

Chi T. Viet

New York University · US
Area of research
Psychiatry and Mental health · Otorhinolaryngology
Research interest
Research interests include Medicine, Cancer, Head and neck squamous-cell carcinoma, Perineural invasion, Mucositis, and Cancer research.
h-index
citations
563
works
16
NIH funding
primary concept
email

Recent publications

Artificial Intelligence Applications in Oral Cancer and Oral Dysplasia
Tissue Engineering Part A 2024cited by 14position: firstdoi
Perineural Invasion Is Associated With Function-evoked Pain and Altered Extracellular Matrix in Patients With Head and Neck Squamous Cell Carcinoma
Journal of Pain 2024cited by 12position: middledoi
Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinoma
npj Precision Oncology 2024cited by 12position: firstdoi
Benefits and Controversies of Midface and Maxillary Reconstruction
Atlas of the Oral and Maxillofacial Surgery Clinics 2024cited by 5position: lastdoi
Stimulator of Interferon Genes Pathway Activation through the Controlled Release of STINGel Mediates Analgesia and Anti-Cancer Effects in Oral Squamous Cell Carcinoma
Biomedicines 2024cited by 4position: lastdoi
Advances in Head and Neck Cancer Pain
Journal of Dental Research 2022cited by 46position: middledoi
Neurotrophin Pathway Receptors NGFR and TrkA Control Perineural Invasion, Metastasis, and Pain in Oral Cancer
Advanced Biology 2022cited by 23position: lastdoi
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinoma
Biomarker Research 2021cited by 32position: firstdoi
Anti-cancer and analgesic effects of resolvin D2 in oral squamous cell carcinoma
Neuropharmacology 2018cited by 75position: middledoi
OPRM1 Methylation Contributes to Opioid Tolerance in Cancer Patients
Journal of Pain 2017cited by 39position: firstdoi
Cutaneous pigmentation modulates skin sensitivity via tyrosinase-dependent dopaminergic signalling
Scientific Reports 2017cited by 20position: middledoi
Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice
Cancer Medicine 2016cited by 69position: middledoi
Decitabine Rescues Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma
PLoS ONE 2014cited by 63position: firstdoi
Adenosine triphosphate drives head and neck cancer pain through P2X2/3 heterotrimers
Acta Neuropathologica Communications 2014cited by 54position: middledoi
Review of Preclinical Studies on Treatment of Mucositis and Associated Pain
Journal of Dental Research 2014cited by 53position: firstdoi
Demethylating Drugs as Novel Analgesics for Cancer Pain
Clinical Cancer Research 2014cited by 42position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Brian L. Schmidt · New York University8 papers (2014–2018)Yi Ye · New York University7 papers (2014–2024)Bradley E. Aouizerat · New York University6 papers (2017–2024)Kentaro Ono · New York University5 papers (2014–2018)Dongmin Dang · New York College of Health Professions5 papers (2014–2022)Carissa M. Thomas · University of Colorado Anschutz Medical Campus4 papers (2021–2024)Gary Yu · New York University3 papers (2021–2024)Dan T. Viet · New York University3 papers (2017–2022) · 3 papers (2021–2024)Nicholas Callahan · University of Illinois Chicago3 papers (2021–2024)John C. Dolan · New York University3 papers (2014–2018)Kesava Asam · New York University3 papers (2021–2024)Clint Allen · National Institutes of Health2 papers (2021–2022)Simon Young · University of Houston2 papers (2024–2024)Daniel Galera Bernabé · New York University2 papers (2014–2018)Michael Zhang · Sydney Hospital2 papers (2024–2024)Steve Lee · University of Arkansas for Medical Sciences2 papers (2021–2022)Khánh Nguyễn · University of California, Riverside2 papers (2021–2022) · 2 papers (2021–2022)Paul C. Walker · University of Michigan–Ann Arbor2 papers (2021–2022)